Microvision Inc

This proposal requests shareholder approval to permit the issuance of common stock that could result from conversions or issuances under the company’s 2026 Convertible Notes, which were issued on February 23, 2026 in an aggregate principal amount of $43 million. Under Nasdaq Listing Rule 5635(d), shareholder approval is required for an issuance that could equal or exceed 20% of outstanding shares when issued at a price below the Minimum Price; obtaining this approval would remove the conversion cap (61,315,971 shares) that otherwise limits share issuance under the notes. Management and the Board argue that approval preserves the company’s ability to settle conversion or redemption obligations in shares rather than cash, conserving cash resources and mitigating liquidity strain; without approval the company may be forced to make substantial cash payments, increasing cash burn and potentially jeopardizing financing prospects. The Purchase Agreement with the Holder requires the company to use best efforts to obtain approval and contemplates repeated special meetings until approval is obtained if the Annual Meeting vote fails, indicating material commercial consequences of rejection. The Board recommends FOR approval on the basis that the Convertible Notes are senior secured debt that support near-term liquidity and strategic execution, while also noting customary anti-dilution protections and conversion price mechanics. Risks include potential dilution to existing shareholders if conversions occur and the fact that the conversion price may be below current market prices, depending on stock performance; the proposal balances immediate cash preservation against potential dilution. From a governance perspective, the transaction was negotiated with an institutional investor and the Board asserts no substantial direct interests by officers or directors, though conversion outcomes will affect ownership percentages. Approval would align the company’s capital structure with its financing plan to support commercialization and operations while providing flexibility for future capital needs.

The proposal asks shareholders to empower the Board to implement a reverse stock split at any whole-number ratio between 1-for-5 and 1-for-15 and to concurrently reduce authorized common shares from 510 million to 150 million, with the Board deciding the ratio and timing within one year. Management frames the split as a tool to regain compliance with Nasdaq’s $1.00 minimum bid-price requirement (or to facilitate a transfer to the Nasdaq Capital Market), improve the stock’s appeal to institutional investors, and preserve capital-raising flexibility; the definitive proxy explicitly states the Board modified the proposal after retail shareholder feedback to reduce authorized shares to 150 million to dispel concerns the split would facilitate future excessive dilution. The amendment, if effected, would reduce outstanding share counts and likely increase per-share market price, but the company cautions that market reaction may not be proportional and liquidity could be adversely affected; the proposal also warns of anti-takeover effects because the post-split increase in authorized but unissued shares could be used to dilute hostile bidders. The Board’s recommendation cites immediate listing risk and the strategic importance of maintaining Nasdaq listing and capital access; it also reserves the right to abandon the split even if authorized, and to determine not to proceed if conditions are unfavorable. The proxy provides concrete examples of post-split outstanding and authorized-available shares at illustrative ratios, and describes procedural, accounting, and fractional-share handling mechanics. Analysts should weigh the likelihood that the split will restore compliance and attract different investor classes against dilution concerns, potential reduced liquidity, and the asymmetry that authorized shares will not be reduced proportionally to outstanding shares, which increases the pool of authorized-for-issuance shares available post-split.

This non-binding advisory proposal asks shareholders to endorse the disclosed 2025 compensation paid to the company’s named executive officers. Management emphasizes a pay-for-performance philosophy, using at-risk compensation (including RSUs tied to performance and service conditions) to align executives with long-term shareholder value, and notes use of an independent compensation consultant in designing pay programs. A vote FOR signals shareholder acceptance of pay structure, allowing the Compensation Committee to consider the outcome when setting future compensation; a vote AGAINST would be advisory but could trigger engagement and potential changes to compensation practices. The proxy details significant elements such as performance-based RSUs, bonus targets tied to revenue and cash-operating-expense metrics, severance arrangements, and inducement awards for certain executives, which together shape both incentive alignment and potential dilution. Key considerations for assessment include the degree to which pay outcomes are tied to measurable performance (revenue, cash discipline, stock-price-based PRSUs), the balance of cash versus equity compensation given the company’s cash constraints, and recent leadership changes that affected compensation outcomes. The Board recommends FOR, citing recruitment and retention needs during commercialization and the desire to link pay to execution of strategic goals; dissenting shareholders often weigh dilution, one-time inducements, and realized pay versus performance when evaluating say-on-pay proposals. As an advisory vote, it carries no binding effect but remains an important governance signal influencing future pay decisions.